Nearly 9 Million Pfizer Shots in Teens, Serious Side Effects Rare

Nearly 9 Million Pfizer Shots in Teens, Serious Side Effects Rare

“Vaccinating 12- to 17-year-olds remains the safer choice for this age group and will reduce school interruptions and transmission to others,” said Mendel Singer, vice chair for education at Case Western Reserve University School of Medicine in Cleveland and co-author of the medRxiv study. Dr. Paul Offit, director of the Vaccine Education Center at … Read more

Roche announces launch of Evrysdi® (risdiplam) for treatment of SMA patients in India

Roche announces launch of Evrysdi® (risdiplam) for treatment of SMA patients in India

Evrysdi® was first approved by the US FDA in August 2020 and is today available in India within 11 months of the US approval. Roche today announced the launch of Evrysdi® (risdiplam), the first and only approved treatment in India for Spinal Muscular Atrophy (SMA) patients. Evrysdi® (risdiplam) is the first and only oral treatment … Read more

Clues to Rare Disorder Affecting Kids With COVID-19

Clues to Rare Disorder Affecting Kids With COVID-19

TUESDAY, May 18, 2021 (HealthDay News) — New insight into a rare and dangerous disorder that can occur in kids with COVID-19 could improve treatment of the condition, researchers say. Many children infected with SARS-CoV-2 (the virus that causes COVID-19) go undiagnosed or have no symptoms, but about one in 1,000 develop a condition … Read more

Post-COVID Viral Transmission Rare, Even With Positive Test

Post-COVID Viral Transmission Rare, Even With Positive Test

FRIDAY, April 23, 2021 (HealthDay News) — Isolated NBA players who recovered from COVID-19 but still tested positive for the virus didn’t infect others after leaving isolation, a new study finds. That someone who has had COVID can infect others has been a persistent fear, but these findings from the professional basketball league suggest … Read more

New Hope Against a Rare but Incurable Eye Cancer

New Hope Against a Rare but Incurable Eye Cancer

By Dennis Thompson HealthDay Reporter TUESDAY, April 20, 2021 (HealthDay News) — A cutting-edge experimental drug cuts nearly in half the risk of death among patients with a rare but aggressive cancer of the eye, new clinical trial data show. Tebentafusp has now become the first drug shown to improve overall survival in patients with … Read more

NIH Looking Into Rare Allergic Reactions to COVID Vaccines

NIH Looking Into Rare Allergic Reactions to COVID Vaccines

THURSDAY, April 8, 2021 (HealthDay News) — A new clinical trial will investigate whether people who are highly allergic or have what’s known as a mast cell disorder are at higher risk for a sudden allergic reaction to the Moderna or Pfizer COVID-19 vaccines. “The public understandably has been concerned about reports of rare, … Read more